Dr James Campbell
Chair, Prescient Therapeutics Ltd
Dr James Campbell is a senior biotechnology executive with a successful career that spans from bench research, academic technology transfer, establishment of early-stage start-ups, leading private and public companies, and being involved in hundred million-dollar deals. With more than 25 years’ experience in research, research management, consulting and venture capital in Australia and internationally, Dr Campbell has a unique set of skills that enable him to identify and monetise future trends in the biotech and pharmaceutical industries.
Dr Campbell chairs the Board of ASX-listed biotech company Prescient Therapeutics, and was the CEO of ASX-listed Patrys Limited for 10 years. Dr Campbell has previously served on the Advisory Board for the Centre for Innovation in Mental and Physical Health and Clinical Treatment at Deakin University, the IP and Commercialisation Committee of the Cooperative Research Centre for Mental Health as well as several government advisory panels.
Holding a PhD in plant biochemistry, Dr Campbell completed a MBA at the Melbourne Business School, and is a Graduate of the Australian Institute of Company Directors.